VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans

Nitya Nair, Ningguo Feng, Lisa K. Blum, Mrinmoy Sanyal, Siyuan Ding, Baoming Jiang, Adrish Sen, John M. Morton, Xiao Song He, William H. Robinson, Harry B. Greenberg

Research output: Contribution to journalArticlepeer-review

72 Scopus citations


Human rotaviruses (RVs) are the leading cause of severe diarrhea in young children worldwide. The molecular mechanisms underlying the rapid induction of heterotypic protective immunity to RV, which provides the basis for the efficacy of licensed monovalent RV vaccines, have remained unknown for more than 30 years. We used RV-specific single cell-sorted intestinal B cells from human adults, barcode-based deep sequencing of antibody repertoires, monoclonal antibody expression, and serologic and functional characterization to demonstrate that infection-induced heterotypic immunoglobulins (Igs) primarily directed to VP5, the stalk region of the RV attachment protein, VP4, are able to mediate heterotypic protective immunity. Heterotypic protective Igs against VP7, the capsid glycoprotein, and VP8, the cell-binding region of VP4, are also generated after infection; however, our data suggest that homotypic anti-VP7 and non-neutralizing VP8 responses occur more commonly in people. These results indicate that humans can circumvent the extensive serotypic diversity of circulating RV strains by generating frequent heterotypic neutralizing antibody responses to VP7, VP8, and most often, to VP5 after natural infection. These findings further suggest that recombinant VP5 may represent a useful target for the development of an improved, third-generation, broadly effective RV vaccine and warrants more direct examination.

Original languageEnglish
JournalScience translational medicine
Issue number395
StatePublished - Jun 21 2017


Dive into the research topics of 'VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans'. Together they form a unique fingerprint.

Cite this